
Zomedica Corp. ZOM
Annual report 2025
added 03-16-2026
Country |
|
IPO year |
2017 |
Industry |
Drug manufacturers |
Stock Exchange |
NYSE AMERICAN |
Shares |
980 M |
Market Cap[1] |
$ 98 M |
EBITDA (LTM) |
$ -84.7 M |
P/E (LTM) |
- |
P/S (LTM) |
3.43 |
EPS (LTM) |
-0.1 |
Other stocks of industry "Drug manufacturers"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Aerie Pharmaceuticals
AERI
|
- | - | $ 754 M | Nasdaq Global Market,SPB | ||
|
AcelRx Pharmaceuticals
ACRX
|
- | 7.5 % | $ 6.35 M | Nasdaq Global Market | ||
|
Agile Therapeutics
AGRX
|
- | 10.11 % | $ 58.2 M | Nasdaq Capital Market | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
- | 0.86 % | $ 117 M | Nasdaq Capital Market | ||
|
Cumberland Pharmaceuticals
CPIX
|
$ 4.06 | 4.1 % | $ 57.1 M | Nasdaq Global Select Market | ||
|
Catalent
CTLT
|
- | - | $ 11.5 B | NYSE,SPB | ||
|
Cronos Group
CRON
|
$ 2.68 | 3.08 % | $ 1.37 B | Nasdaq Global Market | ||
|
DURECT Corporation
DRRX
|
- | - | $ 50.1 M | Nasdaq Capital Market | ||
|
Alimera Sciences
ALIM
|
- | - | $ 142 M | Nasdaq Global Market | ||
|
Athenex
ATNX
|
- | -23.39 % | $ 1.76 M | Nasdaq Global Select Market | ||
|
Eagle Pharmaceuticals
EGRX
|
- | -39.89 % | $ 27.7 M | Nasdaq Global Market,SPB | ||
|
Endo International plc
ENDP
|
- | - | $ 28.9 M | Nasdaq Global Select Market,SPB | ||
|
Avadel Pharmaceuticals plc
AVDL
|
- | - | $ 2.06 B | Nasdaq Global Select Market | ||
|
Evoke Pharma
EVOK
|
- | - | $ 36.6 M | Nasdaq Capital Market | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
- | -0.1 % | $ 2.03 B | Nasdaq Global Select Market | ||
|
HEXO Corp.
HEXO
|
- | 2.45 % | $ 38.1 M | NYSE | ||
|
Bausch Health Companies
BHC
|
$ 5.63 | 1.53 % | $ 2.05 B | NYSE | ||
|
Organogenesis Holdings
ORGO
|
$ 2.35 | 0.86 % | $ 309 M | Nasdaq Capital Market | ||
|
Canopy Growth Corporation
CGC
|
$ 1.19 | -2.87 % | $ 128 M | Nasdaq Global Select Market | ||
|
Pacira BioSciences
PCRX
|
$ 24.51 | -3.35 % | $ 1.13 B | Nasdaq Global Select Market,SPB | ||
|
Harrow Health
HROW
|
$ 39.7 | 2.45 % | $ 1.46 B | Nasdaq Global Market | ||
|
Jupiter Wellness
JUPW
|
- | - | $ 33.6 M | Nasdaq Global Select Market | ||
|
Lannett Company
LCI
|
- | 1.15 % | $ 7.11 M | NYSE | ||
|
Sonoma Pharmaceuticals
SNOA
|
$ 1.14 | -36.67 % | $ 1.41 M | Nasdaq Capital Market | ||
|
OrganiGram Holdings
OGI
|
$ 1.45 | 0.7 % | $ 402 M | Nasdaq Global Select Market | ||
|
Tilray
TLRY
|
$ 6.75 | -2.74 % | $ 4.17 B | Nasdaq Global Select Market | ||
|
Evolus
EOLS
|
$ 5.3 | -0.19 % | $ 342 M | Nasdaq Global Market | ||
|
Sundial Growers
SNDL
|
$ 1.51 | -1.31 % | $ 3.37 M | Nasdaq Global Select Market | ||
|
Emergent BioSolutions
EBS
|
$ 8.03 | -0.74 % | $ 411 M | NYSE,SPB | ||
|
Veru
VERU
|
$ 2.32 | 0.43 % | $ 313 M | Nasdaq Capital Market | ||
|
Neoleukin Therapeutics
NLTX
|
- | - | $ 193 M | Nasdaq Global Select Market | ||
|
Viatris
VTRS
|
$ 14.59 | -1.08 % | $ 17.5 B | Nasdaq Global Select Market,SPB | ||
|
ProPhase Labs
PRPH
|
- | - | $ 5.07 M | Nasdaq Capital Market | ||
|
cbdMD
YCBD
|
$ 1.01 | - | $ 4.36 M | NYSE American | ||
|
Assertio Holdings
ASRT
|
$ 18.04 | 0.11 % | $ 116 M | Nasdaq Capital Market | ||
|
PetIQ
PETQ
|
- | 1.64 % | $ 400 M | Nasdaq Global Select Market,SPB | ||
|
Solid Biosciences
SLDB
|
$ 7.92 | -3.65 % | $ 693 M | Nasdaq Global Select Market,SPB | ||
|
Relmada Therapeutics
RLMD
|
$ 7.21 | -0.55 % | $ 285 M | Nasdaq Global Select Market,SPB | ||
|
Radius Health
RDUS
|
- | - | $ 1.42 B | Nasdaq Global Market | ||
|
Recro Pharma
REPH
|
- | -4.76 % | $ 65.3 M | Nasdaq Global Select Market | ||
|
OptiNose
OPTN
|
- | - | $ 1.08 B | Nasdaq Global Select Market | ||
|
SCYNEXIS
SCYX
|
$ 1.02 | -2.86 % | $ 50.9 M | Nasdaq Global Select Market | ||
|
PLx Pharma
PLXP
|
- | -27.8 % | $ 2.56 M | Nasdaq Capital Market | ||
|
Aurora Cannabis
ACB
|
$ 3.39 | 3.35 % | $ 86.3 M | NYSE | ||
|
Zynerba Pharmaceuticals
ZYNE
|
- | - | $ 55.5 M | Nasdaq Global Market,SPB | ||
|
Rockwell Medical
RMTI
|
$ 0.87 | 1.99 % | $ 31.3 M | Nasdaq Global Market | ||
|
Tricida
TCDA
|
- | - | $ 3.25 M | Nasdaq Global Select Market,SPB | ||
|
China Pharma Holdings
CPHI
|
$ 0.61 | 1.65 % | $ 2.62 M | NYSE American | ||
|
TherapeuticsMD
TXMD
|
$ 2.19 | 0.46 % | $ 25.3 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.